Damora Therapeutics, Inc.

Denmark

Last price 21.67 USD (Oct 30, 2026, 2:14 PM EDT) · Market cap 1.34B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company’s lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of essential thrombocythemia; and DMR-002 and DMR-003, both anti-mutCALR-based therapies, with the intent to ultimately address the full spectrum of mutCALR MPN patients. It also develops GB3226, a small molecule inhibitor of ENL-YEATS and FLT3 for the treatmen...